Logo

Caplin Point Laboratories Ltd. Share Price

Pharmaceuticals & Drugs

Caplin Point Laboratories Ltd. (INR)2161.1151.1   (7.5%)

Exchange ScripsBSE524742NSECAPLIPOINTISININE475E01026

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Caplin Point Laboratories Ltd. Performance

Market performance

Open price2024
High2188
Volumes587808
Prev Close2161.1
Low2008.6
Closing date2025-05-19

Historical performance

1 Year High2641.00
3 Year High2641.00
5 Year High2641.00
1 Year Low1225.00
3 Year Low575.00
5 Year Low305.10

Caplin Point Laboratories Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
16436
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
35.91
Dividend Yield
Dividend Yield
0.12 %

Caplin Point Laboratories Ltd. Investment Returns

1 Year
64.3%
3 Years
170%
5 Years
568.3%
10 Years
994.1%

Caplin Point Laboratories Ltd. Technicals

IndicatorsValueSignal
5-DMA2038.12Bullish
10-DMA1961.29Bullish
20-DMA1921.75Bullish
50-DMA1921.41Bullish
100-DMA2061.39Bullish
200-DMA2006.68Bullish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters77777
Foreign Investors---------------
Domestic Investors77777
Public Investors9638092695961168040481402
Government---------------

Caplin Point Laboratories Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income669565389279
Operating Profit6184497043343522
Interest88716
Depreciation534450469370
Profit Before Tax5644451438583136
Consolidated Net Profit4571376329982423
Adjusted EPS60504032

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital898898897897
Total Reserves22117177531378710813
Minority Interest311268260175
Total Non-Current Liabilities7521126174
Total Liabilities26856217741730113636
Capital Work in Progress11662205154138
Total Assets26856217741730113636

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities3184271433672686
Cash Flow from Investing Activities-3200-2176-3768-294
Cash Flow from Financing Activitie-381-282-407-240
Net Cash Inflow / Outflow-397256-8072152
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 35.91.
  • 3Y Stock Price CAGR of the stock is 40.7.
  • The stock has a beta of 1.3.
  • In the last financial year, the company had an EBITDA of ₹6184 Million.
  • The company generated revenue of ₹16941 Million in the previous financial year.

Caplin Point Laboratories Ltd.

2161.1151.1   (7.5%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1674427.6
No. of Shares: 774.8
Performance:67.4%
P/L: ₹674427.6

Top Gainers

SymbolChange%
BANCOINDIA494.5(20%)
ZODIAC529.7(20%)
KAYA342.35(20%)
PREMEXPLN583.85(18%)
FOODSIN109.77(17%)

Top Losers

SymbolChange%
PROTEAN1143.2(-20%)
BBL3096.1(-10%)
MUKANDLTD108.84(-10%)
GLOBAL59.65(-9%)
IDEA6.72(-9%)
PREMIERPOL54.92(-9%)
ASIANENE311.85(-8%)
GAEL115.79(-7%)

Similar stocks

Suven Life Sciences Ltd.

64.6

207.98

April 19 - May 19

Aarti Drugs Ltd.

34.5

480.6

April 19 - May 19

Themis Medicare Ltd.

27.1

170.74

April 19 - May 19

NGL Fine-Chem Ltd.

26.3

1313.6

April 19 - May 19

Kilitch Drugs (India) Ltd.

25.4

439.6

April 19 - May 19

SMS Pharmaceuticals Ltd.

22.7

266.4

April 19 - May 19

IOL Chemicals And Pharmaceuticals Ltd.

22

81.4

April 19 - May 19

Morepen Laboratories Ltd.

21.6

63.67

April 19 - May 19

Announcing Stock of the Month!

Stock of the Month
Stock of the Month